TrismusTRISMUSNCT05615181
Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)
An observational study of Trismus, run by Centre Hospitalier de Valence at 1 site in France.
Trial summary
A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Trismus
- How many people
- 310 participants
- Where
- 1 siteFrance
- Study dates
- 22 Dec 2020to 31 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patient treated for trismus
Who may be able to join
- Patient treated for trismus
- Age ≥ 18 years old
- Read, write and understand the French language
Who cannot join
- Patient under guardianship, deprived of liberty, safeguard of justice
- Refusal to participate in research
Trial locations and contacts
1 site in 1 country.
About this study
A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).
Read the detailed description
Trismus is defined as a limitation in the mouth/jaw-opening ability due to a reduced mandible mobility. Trismus can occur from benign jaw related conditions, often referred to as temporomandibular disorders (TMD). It can also result from local or metastatic tumor growth of head and neck (H\&N) tumors, and more importantly, as a debilitating side-effect to H\&N oncology treatment, especially radiotherapy
The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language.
The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .
- Conditions
- Trismus
- Keywords
- trismus, Patient reported outcomes, u Gothenburg Trismus Questionnaire
- Medical subject headings
- Trismus
What is being measured
The primary outcome is the main question the study is designed to answer.
Gothenburg Trismus Questionnaire (GTQ)
patient Reported Outcome measure: score 0-4 (0 means a better outcome, 4 means a worse outcome.)
Measured: once at inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2022
- Study start22 Dec 2020
- Primary completion31 Dec 2022
- Study completion31 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TrismusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 310 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Valence
- Sponsor type
- University, hospital or other
- Collaborators
- Göteborg University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05615181
- Sponsor's protocol ID
- RIPH-CHV-06
- Acronym
- TRISMUS
- Status last verified
- Sep 2025
- First submitted
- 7 Nov 2022
- Last updated
- 8 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)
- ClinicalTrials.gov ID
- NCT05615181
- Acronym / sponsor ID
- TRISMUS / RIPH-CHV-06
- Conditions
- Trismus
- Keywords
- trismus, Patient reported outcomes, u Gothenburg Trismus Questionnaire
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 310 participants (actual)
- Lead sponsor
- Centre Hospitalier de ValenceUniversity, hospital or other
- Collaborators
- Göteborg University
- Study start
- 22 Dec 2020 (actual)
- Primary completion
- 31 Dec 2022 (actual)
- Study completion
- 31 Dec 2022 (actual)
- First posted
- 14 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).
Detailed description
Trismus is defined as a limitation in the mouth/jaw-opening ability due to a reduced mandible mobility. Trismus can occur from benign jaw related conditions, often referred to as temporomandibular disorders (TMD). It can also result from local or metastatic tumor growth of head and neck (H\&N) tumors, and more importantly, as a debilitating side-effect to H\&N oncology treatment, especially radiotherapy
The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language.
The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patient treated for trismus
Key inclusion criteria (3 listed)
Key exclusion criteria (2 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Gothenburg Trismus Questionnaire (GTQ)
Time frame: once at inclusion
patient Reported Outcome measure: score 0-4 (0 means a better outcome, 4 means a worse outcome.)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Trismus
Not yet recruiting
Autologous PRP Versus Triamcinolone Acetate in Patients With Oral Submucous Fibrosis
Oral Submucous Fibrosis
Recruiting
Aescin-Based Herbal Extract (Reparil) for Postoperative Sequelae After Mandibular Third Molar Surgery
Postoperative Pain, Facial Swelling
Recruiting
Swallowing Rehabilitation Program for Head and Neck Tumor Patients
Head and Neck Cancer (H&N)
RecruitingPhase 2
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
Throat Carcinoma
Recruiting
Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus
Head and Neck Cancer, Trismus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Trismus, run by Centre Hospitalier de Valence at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gothenburg Trismus Questionnaire (GTQ) (time frame: once at inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.